BG28052A4 - Метод за получаване на аминоалкилхетероцикли - Google Patents

Метод за получаване на аминоалкилхетероцикли

Info

Publication number
BG28052A4
BG28052A4 BG036629A BG3662977A BG28052A4 BG 28052 A4 BG28052 A4 BG 28052A4 BG 036629 A BG036629 A BG 036629A BG 3662977 A BG3662977 A BG 3662977A BG 28052 A4 BG28052 A4 BG 28052A4
Authority
BG
Bulgaria
Prior art keywords
heterocycles
aminoalkyl
obtaining
proven
formulated
Prior art date
Application number
BG036629A
Other languages
English (en)
Inventor
Anton Mentrup
Kurt Schromm
Ottoernst Renth
Richard Reichl
Werner Traunecker
Wolfgang Hoefke
Original Assignee
C.H.Boehringer Sohn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C.H.Boehringer Sohn filed Critical C.H.Boehringer Sohn
Publication of BG28052A4 publication Critical patent/BG28052A4/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nonwoven Fabrics (AREA)
  • Laminated Bodies (AREA)
  • Hydrogenated Pyridines (AREA)
  • Quinoline Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Метод за получаване на охарактеризирани и доказани в описанието аминоалкилхетероцикли с формула.... Патентните претенции са формулирани в 1 точка.
BG036629A 1976-03-09 1977-03-07 Метод за получаване на аминоалкилхетероцикли BG28052A4 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762609645 DE2609645A1 (de) 1976-03-09 1976-03-09 Aminoalkylheterocyclen

Publications (1)

Publication Number Publication Date
BG28052A4 true BG28052A4 (bg) 1980-02-25

Family

ID=5971857

Family Applications (4)

Application Number Title Priority Date Filing Date
BG036628A BG28051A4 (bg) 1976-03-09 1977-03-07 Метод за получаване на аминоалкилхетероцикли
BG036629A BG28052A4 (bg) 1976-03-09 1977-03-07 Метод за получаване на аминоалкилхетероцикли
BG035601A BG27743A3 (bg) 1976-03-09 1977-03-07 Метод за получаване на аминоалкил-хетероцикли
BG036630A BG28053A4 (bg) 1976-03-09 1978-06-14 Метод за получаване на аминоалкилхетероцикли

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BG036628A BG28051A4 (bg) 1976-03-09 1977-03-07 Метод за получаване на аминоалкилхетероцикли

Family Applications After (2)

Application Number Title Priority Date Filing Date
BG035601A BG27743A3 (bg) 1976-03-09 1977-03-07 Метод за получаване на аминоалкил-хетероцикли
BG036630A BG28053A4 (bg) 1976-03-09 1978-06-14 Метод за получаване на аминоалкилхетероцикли

Country Status (36)

Country Link
US (4) US4154829A (bg)
JP (2) JPS52108970A (bg)
AT (1) AT360542B (bg)
AU (1) AU515953B2 (bg)
BE (1) BE852223A (bg)
BG (4) BG28051A4 (bg)
CA (1) CA1086317A (bg)
CH (8) CH630358A5 (bg)
CS (2) CS220320B2 (bg)
DD (1) DD130037A5 (bg)
DE (1) DE2609645A1 (bg)
DK (1) DK102177A (bg)
ES (10) ES456622A1 (bg)
FI (1) FI69070C (bg)
FR (2) FR2343731A1 (bg)
GB (1) GB1571231A (bg)
GR (1) GR64553B (bg)
HK (1) HK12884A (bg)
HU (1) HU177953B (bg)
IE (1) IE45300B1 (bg)
IL (1) IL51627A (bg)
LU (1) LU76898A1 (bg)
MX (1) MX4878E (bg)
MY (1) MY8500079A (bg)
NL (1) NL7702403A (bg)
NO (1) NO147950C (bg)
NZ (1) NZ183536A (bg)
PH (3) PH16110A (bg)
PL (2) PL112937B1 (bg)
PT (1) PT66282B (bg)
RO (3) RO79706A (bg)
SE (1) SE435059B (bg)
SG (1) SG55583G (bg)
SU (4) SU698530A3 (bg)
YU (1) YU62377A (bg)
ZA (1) ZA771412B (bg)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
DE2644833A1 (de) * 1976-10-05 1978-04-20 Boehringer Sohn Ingelheim Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen
FR2455572B1 (fr) 1979-05-04 1986-07-25 Continental Pharma Derives de phenylethylamine, leur preparation et utilisation dans le traitement des affections cardiovasculaires, et compositions les contenant
DE3026534A1 (de) * 1980-07-12 1982-03-18 C.H. Boehringer Sohn, 6507 Ingelheim 3,1-benzoxazin-2-one, ihre herstellung und verwendung
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
DE3325875A1 (de) * 1983-07-18 1985-01-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue 1-phenylimidazolidin-2-on-derivate, ihre herstellung und verwendung
US4743613A (en) * 1986-04-08 1988-05-10 Smithkline Beckman Corporation Ester prodrugs of dopamine-β-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-β-hydroxylase activity
GB8609331D0 (en) * 1986-04-16 1986-05-21 Pfizer Ltd Anti-arrythmia agents
TW203049B (bg) * 1990-04-13 1993-04-01 Yamanouchi Pharma Co Ltd
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
US5808080A (en) * 1996-09-05 1998-09-15 Eli Lilly And Company Selective β3 adrenergic agonists
ES2171839T3 (es) 1996-09-05 2002-09-16 Lilly Co Eli Analogos de carbazol como agonistas adrenergicos selectivos de beta3.
CO5011072A1 (es) 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores
SI1598339T1 (sl) * 2001-04-18 2009-12-31 Euro Celtique Sa Derivati 1-(4-amino.cikloheksil)-1,3-dihidro-2h-benzimidazol-2-ona in sorodne spojine kot nociceptinski analogi in ORL1 ligandi za zdravljenje bolečine
CN1516584A (zh) 2001-04-18 2004-07-28 ŷ�����ǹɷ����޹�˾ 螺吡唑化合物
CA2443938C (en) 2001-04-18 2010-06-22 R. Richard Goehring Spiroindene and spiroindane compounds as opioid ligands useful for treating pain
KR100855204B1 (ko) * 2001-04-18 2008-09-01 유로-셀티크 소시에떼 아노뉨 노시셉틴 유사체
CA2444489C (en) 2001-04-18 2010-06-22 Euro-Celtique, S.A. Benzimidazolone compounds
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
JP2006509790A (ja) * 2002-11-27 2006-03-23 アルテシアン セラピューティック，インコーポレイティド 心不全の治療のための混合されたＰＤＥ阻害およびβアドレナリン拮抗薬活性または部分的作用薬活性を有する化合物
JP2006513222A (ja) * 2002-12-23 2006-04-20 アルテシアン セラピューティック，インコーポレイティド アドレナリン性β受容体およびホスホジエステラーゼに対する抑制活性を有する強心性化合物
DE102004001413A1 (de) * 2004-01-09 2005-08-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-Hydroxymethyl-4-Hydroxy-Phenyl-Derivate zur Behandlung von chronisch obstruktiver Lungenerkrankung
DE102004003428A1 (de) * 2004-01-23 2005-08-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel
US20050272726A1 (en) * 2004-04-22 2005-12-08 Boehringer Ingelheim International Gmbh Novel medicaments for the treatment of respiratory diseases
DE102004021779A1 (de) * 2004-04-30 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
US20050256115A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta-agonists
US7220742B2 (en) * 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004045648A1 (de) * 2004-09-21 2006-03-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika zur Behandlung von Atemwegserkrankungen
US20080255134A1 (en) * 2004-11-30 2008-10-16 Artesian Therapeutics, Inc. Cardiotonic Compounds With Inhibitory Activity Against Beta-Adrenergic Receptors And Phosphodiesterase
CA2588949A1 (en) * 2004-11-30 2006-06-08 Artesian Therapeutics, Inc. Compounds with mixed pde-inhibitory and .beta.-adrenergic antagonist or partial agonist activity for treatment of heart failure
DE102005007654A1 (de) * 2005-02-19 2006-08-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Betamimetika zur Behandlung von Atemwegserkrankungen
DE102005030733A1 (de) * 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
MX2008001976A (es) * 2005-08-15 2008-03-25 Boehringer Ingelheim Int Procedimiento para la preparacion de betamimeticos.
DE102005052127A1 (de) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue indol-haltige Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102005052102A1 (de) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102005052101A1 (de) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
CA2642239A1 (en) * 2006-02-16 2007-08-23 Boehringer Ingelheim International Gmbh Drug combinations for the treatment of respiratory tract diseases
PE20080142A1 (es) * 2006-03-15 2008-04-14 Boehringer Ingelheim Int Beta-agonistas enantiomericamente puros y sus procedimientos de preparacion
CA2660186A1 (en) 2006-08-07 2008-02-14 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of respiratory diseases
US8686008B2 (en) * 2007-08-16 2014-04-01 The University Of Mississippi Highly selective sigma receptor ligands
US9604926B2 (en) 2007-08-16 2017-03-28 The University Of Mississippi Highly selective sigma receptor radioligands
WO2009026227A2 (en) * 2007-08-16 2009-02-26 The University Of Mississippi Highly selective sigma receptor ligands

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA631296A (en) * 1961-11-21 L. Clark Robert Substituted benzimidazolones
CH149009A (de) * 1929-08-10 1931-08-15 Chem Ind Basel Verfahren zur Darstellung einer N-substituierten Verbindung der Pyridonreihe.
US2857394A (en) * 1957-05-10 1958-10-21 Ciba Pharm Prod Inc Heterocyclic compounds
NL284529A (bg) * 1961-10-24
FR1516714A (fr) * 1962-11-07 1968-02-05 Bayer Ag Procédé de préparation de dérivés de l'imidazolidine
FR1384708A (fr) * 1963-11-21 1965-01-08 Thomson Houston Comp Francaise Perfectionnements aux dispositifs de mise en place d'objets
BE659364A (bg) * 1964-02-05
US3355457A (en) * 1965-05-21 1967-11-28 American Cyanamid Co Substituted 2-imidazolinones
FR1573739A (bg) * 1968-07-26 1969-07-04
US3984405A (en) * 1971-06-28 1976-10-05 E. R. Squibb & Sons, Inc. Anti-inflammatory agents
BE787103A (fr) * 1971-08-04 1973-02-02 Pfizer Nouveaux derives de propanolamine et composition pharmaceutiqueles contenant
FR2168140A1 (en) * 1972-01-17 1973-08-31 Bellon Labor Sa Roger Dihydro-benzoxazine derivs - antidepressants
US3925383A (en) * 1972-12-08 1975-12-09 Janssen Pharmaceutica Nv Bicyclic imidazoles and pyrimidines
US3994901A (en) * 1974-06-13 1976-11-30 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxy-3,4-dihydrocarbostyril derivatives
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen

Also Published As

Publication number Publication date
ZA771412B (en) 1978-11-29
FR2372810A1 (fr) 1978-06-30
CH630360A5 (de) 1982-06-15
SU683616A3 (ru) 1979-08-30
ES466603A1 (es) 1978-10-01
CH630361A5 (de) 1982-06-15
JPS6172A (ja) 1986-01-06
BG27743A3 (bg) 1979-12-12
IE45300B1 (en) 1982-07-28
MY8500079A (en) 1985-12-31
HU177953B (en) 1982-02-28
NO147950B (no) 1983-04-05
JPS52108970A (en) 1977-09-12
ES466602A1 (es) 1978-10-01
FI69070C (fi) 1985-12-10
PH16149A (en) 1983-07-12
PH16110A (en) 1983-06-30
YU62377A (en) 1982-10-31
LU76898A1 (bg) 1978-06-01
SU698530A3 (ru) 1979-11-15
AT360542B (de) 1981-01-12
HK12884A (en) 1984-02-24
FI770586A (bg) 1977-09-10
MX4878E (es) 1982-11-26
SU676163A3 (ru) 1979-07-25
CS220320B2 (en) 1983-03-25
BE852223A (fr) 1977-09-08
US4363814A (en) 1982-12-14
US4271158A (en) 1981-06-02
SU685149A3 (ru) 1979-09-05
PH17635A (en) 1984-10-18
US4154829A (en) 1979-05-15
CA1086317A (en) 1980-09-23
CH630362A5 (de) 1982-06-15
AU2300977A (en) 1978-09-14
ES466606A1 (es) 1978-10-01
GR64553B (en) 1980-04-14
CH630364A5 (de) 1982-06-15
NL7702403A (nl) 1977-09-13
NO147950C (no) 1983-07-13
ES456622A1 (es) 1978-03-16
SG55583G (en) 1984-07-27
PL112937B1 (en) 1980-11-29
FR2343731B1 (bg) 1982-02-26
CH630358A5 (de) 1982-06-15
SE7702609L (sv) 1977-10-11
CH630363A5 (de) 1982-06-15
RO79706A (ro) 1982-08-17
NO770804L (no) 1977-09-12
ES466601A1 (es) 1978-10-01
PL196505A1 (pl) 1979-06-18
GB1571231A (en) 1980-07-09
FI69070B (fi) 1985-08-30
PT66282A (pt) 1977-04-01
AU515953B2 (en) 1981-05-14
CH630359A5 (de) 1982-06-15
DD130037A5 (de) 1978-03-01
FR2343731A1 (fr) 1977-10-07
ES466604A1 (es) 1978-10-01
ES466600A1 (es) 1978-10-01
SE435059B (sv) 1984-09-03
NZ183536A (en) 1981-11-19
RO70569A (ro) 1981-11-24
DK102177A (da) 1977-09-10
CS209435B2 (en) 1981-12-31
RO76589A (ro) 1981-04-30
BG28053A4 (bg) 1980-02-25
CH630365A5 (de) 1982-06-15
IE45300L (en) 1977-09-09
ATA122377A (de) 1980-06-15
ES466598A1 (es) 1978-10-01
ES466599A1 (es) 1978-10-01
DE2609645A1 (de) 1977-09-15
US4215119A (en) 1980-07-29
IL51627A (en) 1980-10-26
ES466605A1 (es) 1978-10-01
IL51627A0 (en) 1977-05-31
PT66282B (pt) 1979-01-17
PL111240B1 (en) 1980-08-30
BG28051A4 (bg) 1980-02-25
FR2372810B1 (bg) 1982-11-26

Similar Documents

Publication Publication Date Title
BG28052A4 (bg) Метод за получаване на аминоалкилхетероцикли
BG28065A4 (bg) Метод за получаване на 2-фенил-3-арилбензотиофели
BG37375A3 (bg) Метод за получаване на пролиннови производни
BG33286A3 (bg) Метод за получаване на нови 4-хидрокси-2н-1,2 -бензотиазин-3-карбоксамид-1,1-двуориси,тяхната употреба и съдържащи тези съединения лекарствени средства
BG31496A3 (bg) Метод за получаване на 4-амино-5-алкил-сулфонил ортоанизамиди
BG34338A3 (bg) Метод за получаване на тиадиазолилцефалоспорини
BG33294A3 (bg) Метод за получаване на антитуморни производни на 4-дезацетил vlвс-3 карбоксхидразид
BG36044A3 (bg) Метод за получаване на пиперазинови производни
BG28699A3 (bg) Метод за получаване на алкилендиаминови производни
BG28072A4 (bg) Метод за получаване на 1 n заместени канамицинови производни
BG28573A3 (bg) Метод за получаване на аминоалкоксифенилови производни
BG35039A3 (bg) Метод за получаване на заместени хетероциклични феноксиамини
BG30778A3 (bg) Метод за получаване на ебурнаменинови производни
BG35464A3 (bg) Метод за получаване на флуоренови производни
BG34038A3 (bg) Метод за получаване на 7-заместени амино-ацетамидо оксадетиа-цефалоспорини
BG31073A3 (bg) Метод за получаване на 1,5-заместени-2-пиролидони
BG30175A4 (bg) Метод за получаване на пиридонови съединения
BG28574A3 (bg) Метод за получаване на 4 дифенилметилен 1 хидрокси бензол пиперидини
BG36934A3 (bg) Метод за получаване на сяросъдържащи изохинолинови производни
BG30021A3 (bg) Метод за получаване на имидазоизохинолин-диони
BG28845A3 (bg) Метод за получаване на n-алкилдифениламини
BG28055A3 (bg) Метод за получаване на фенилпиперазинови производни
BG28414A4 (bg) Метод за получаване на 1-хидрокси-тетрахидробензо(с)хинолинони
BG28066A3 (bg) Метод за получаване на пиридобензодиазепинони
BG33283A3 (bg) Метод за получаване на пиридазинилхидразони